首页 > 最新文献

European annals of allergy and clinical immunology最新文献

英文 中文
Pollen-induced asthma: a specific pheno-endotype of disease? 花粉性哮喘:一种特殊的内源性疾病?
IF 2.3 Q2 ALLERGY Pub Date : 2025-09-01 Epub Date: 2025-05-13 DOI: 10.23822/EurAnnACI.1764-1489.403
L Cecchi, M Martini, K Jaubashi, A M Marra, A Musarra, F Papia, A Vaghi, G Valenti, B Yang, M B Bilò

Summary: Asthma is a heterogeneous syndrome with a significant social and economic impact. While the knowledge of pheno-endotypes has advanced in severe asthma, little attention has been paid to the phenotypes of mild-moderate asthma. Along this line, a systematic review of the current literature on pollen-induced asthma was carried out, targeting the question whether it can be considered a specific phenotype of disease, with a focus on the role of pollen and its interplay with asthma. This article reports the first part of the review, which covered background information on the multiple atmospheric and environmental factors affecting pollen concentration, the molecular bases of pollen-induced allergenicity and the pathogenic effector circuits that sustain and amplify inflammatory signals in response to allergens in sensitized subjects.

摘要:哮喘是一种异质性综合征,具有显著的社会和经济影响。虽然对重度哮喘的表型内分型的了解有所进展,但对轻中度哮喘的表型却很少关注。沿着这条思路,对花粉诱导哮喘的现有文献进行了系统回顾,针对花粉是否可以被认为是一种特定的疾病表型的问题,重点关注花粉的作用及其与哮喘的相互作用。本文综述了影响花粉浓度的多种大气和环境因素的背景资料、花粉致敏性的分子基础以及致敏者对过敏原反应中维持和放大炎症信号的致病效应回路。
{"title":"Pollen-induced asthma: a specific pheno-endotype of disease?","authors":"L Cecchi, M Martini, K Jaubashi, A M Marra, A Musarra, F Papia, A Vaghi, G Valenti, B Yang, M B Bilò","doi":"10.23822/EurAnnACI.1764-1489.403","DOIUrl":"10.23822/EurAnnACI.1764-1489.403","url":null,"abstract":"<p><strong>Summary: </strong>Asthma is a heterogeneous syndrome with a significant social and economic impact. While the knowledge of pheno-endotypes has advanced in severe asthma, little attention has been paid to the phenotypes of mild-moderate asthma. Along this line, a systematic review of the current literature on pollen-induced asthma was carried out, targeting the question whether it can be considered a specific phenotype of disease, with a focus on the role of pollen and its interplay with asthma. This article reports the first part of the review, which covered background information on the multiple atmospheric and environmental factors affecting pollen concentration, the molecular bases of pollen-induced allergenicity and the pathogenic effector circuits that sustain and amplify inflammatory signals in response to allergens in sensitized subjects.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":" ","pages":"197-210"},"PeriodicalIF":2.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143971823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and atopic features of patients with wheat allergy dependent on augmentation factors (WALDA) presenting with urticaria: a monocentric study. 小麦过敏患者的临床和特应性特征依赖于荨麻疹的增强因子(WALDA):一项单中心研究。
IF 2.6 Q2 ALLERGY Pub Date : 2025-07-03 DOI: 10.23822/EurAnnACI.1764-1489.407
C M Rossi, S Merli, M V Lenti, M De Amici, A di Sabatino

Summary: Background. Clinical and laboratory features of wheat allergy dependent on augmentation factor (WALDA) are scarcely characterised as compared to wheat anaphylaxis dependent on augmentation factor (WANDA). In this study we assessed the pattern of comorbid atopic and gastrointestinal diseases and the sensitisation profile in patients with WALDA presenting with intermittent urticaria. Methods. We retrospectively assessed all patients with WALDA-urticaria in a tertiary referral center, with a combined gastrointestinal- allergy unit. WALDA diagnosis was based upon recognised clinical/serological criteria, Clinical, atopic features, allergy tests and gastrointestinal comorbidities were compared to a cohort of O5G negative patients sensitised/allergic to wheat and one of patients allergic to shrimp. Results. Overall, we recruited 11 patients with WALDA presenting with intermittent urticaria (median age 44 years, IQR 29-58, F:M ratio 1.7:1). Atopy was a frequent finding among patients (8/11, 72.7%), with food allergy (6/11, 54.5%) followed by respiratory allergies (5/11, 45.5%). Shrimp sensitisation was present in 8/11 patients (72.7%); half of them were also clinically reactive to shrimp. Irritable bowel syndrome (IBS) was present in 4/11 patients (36.3%). The prevalence of shrimp sensitization was 15.3%, (p=0.01), in a group (n=13) of O5G negative patients with wheat sensitisation/allergy (median age 31 years, IQR 27.7-52.0, F:M ratio 0.4:1), while IBS prevalence was 9% (p=0.12).  In the group of patients with shrimp allergy (n=13) with or without allergic rhinitis, the prevalence of O5G positivity was 0% and that of IBS 7.7%. Conclusions. Patients with WALDA-urticaria seems to present specific demographic features (female sex) and atopic (shrimp sensitisation/allergy).

摘要:背景。与依赖于增强因子(WANDA)的小麦过敏反应相比,依赖于增强因子(WALDA)的小麦过敏反应的临床和实验室特征几乎没有特征。在这项研究中,我们评估了伴有间歇性荨麻疹的WALDA患者的共病性特应性和胃肠道疾病的模式以及致敏性。方法。我们回顾性地评估了所有在三级转诊中心的walda -荨麻疹患者,并合并了胃肠道-过敏单元。WALDA诊断基于公认的临床/血清学标准,将临床、特应性特征、过敏试验和胃肠道合并症与对小麦敏感/过敏的O5G阴性患者和对虾过敏的患者进行比较。结果。总的来说,我们招募了11例伴有间歇性荨麻疹的WALDA患者(中位年龄44岁,IQR 29-58, F:M比1.7:1)。患者中常见的是特应性反应(8/11,72.7%),其次是食物过敏(6/11,54.5%),其次是呼吸道过敏(5/11,45.5%)。8/11例患者(72.7%)出现对虾致敏;其中一半的人对虾也有临床反应。4/11(36.3%)患者存在肠易激综合征(IBS)。在O5G阴性小麦致敏/过敏患者组(n=13)(中位年龄31岁,IQR为27.7-52.0,F:M比为0.4:1)中,虾致敏率为15.3% (p=0.01),而IBS患病率为9% (p=0.12)。在伴有或不伴有变应性鼻炎的对虾过敏组(n=13)中,O5G阳性率为0%,IBS阳性率为7.7%。结论。walda荨麻疹患者似乎具有特定的人口统计学特征(女性)和特应性(虾致敏/过敏)。
{"title":"Clinical and atopic features of patients with wheat allergy dependent on augmentation factors (WALDA) presenting with urticaria: a monocentric study.","authors":"C M Rossi, S Merli, M V Lenti, M De Amici, A di Sabatino","doi":"10.23822/EurAnnACI.1764-1489.407","DOIUrl":"https://doi.org/10.23822/EurAnnACI.1764-1489.407","url":null,"abstract":"<p><strong>Summary: </strong><b>Background.</b> Clinical and laboratory features of wheat allergy dependent on augmentation factor (WALDA) are scarcely characterised as compared to wheat anaphylaxis dependent on augmentation factor (WANDA). In this study we assessed the pattern of comorbid atopic and gastrointestinal diseases and the sensitisation profile in patients with WALDA presenting with intermittent urticaria. <b>Methods</b>. We retrospectively assessed all patients with WALDA-urticaria in a tertiary referral center, with a combined gastrointestinal- allergy unit. WALDA diagnosis was based upon recognised clinical/serological criteria, Clinical, atopic features, allergy tests and gastrointestinal comorbidities were compared to a cohort of O5G negative patients sensitised/allergic to wheat and one of patients allergic to shrimp. <b>Results</b>. Overall, we recruited 11 patients with WALDA presenting with intermittent urticaria (median age 44 years, IQR 29-58, F:M ratio 1.7:1). Atopy was a frequent finding among patients (8/11, 72.7%), with food allergy (6/11, 54.5%) followed by respiratory allergies (5/11, 45.5%). Shrimp sensitisation was present in 8/11 patients (72.7%); half of them were also clinically reactive to shrimp. Irritable bowel syndrome (IBS) was present in 4/11 patients (36.3%). The prevalence of shrimp sensitization was 15.3%, (p=0.01), in a group (n=13) of O5G negative patients with wheat sensitisation/allergy (median age 31 years, IQR 27.7-52.0, F:M ratio 0.4:1), while IBS prevalence was 9% (p=0.12).  In the group of patients with shrimp allergy (n=13) with or without allergic rhinitis, the prevalence of O5G positivity was 0% and that of IBS 7.7%. <b>Conclusions.</b> Patients with WALDA-urticaria seems to present specific demographic features (female sex) and atopic (shrimp sensitisation/allergy).</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus on diagnosis and management of hereditary angioedema in Greece. 希腊遗传性血管性水肿的诊断和治疗共识。
IF 2.6 Q2 ALLERGY Pub Date : 2025-07-02 DOI: 10.23822/EurAnnACI.1764-1489.405
A E Germenis, E Kompoti, G N Konstantinou, M Makris, E Manousakis, N Mikos, J Paraskevopoulos, M Speletas, E Stefanaki, E Farmaki, F Psarros

Summary: HAE is a rare disease manifesting with recurrent attacks of disabling and potentially life-threatening angioedema for which early diagnosis and effective therapy are critical. Recent scientific progress and the development of novel therapeutic options has engendered multiple important changes in the diagnosis and management of the disease. In an attempt to encourage and facilitate the use of this progress for all patients, the Hellenic Society of Angioedema has undertaken the effort to develop consensus recommendations for the diagnosis, treatment and management of hereditary angioedema in special patients' groups. To this aim a panel of 11 experts was assembled and a modified Delphi method was used. After a comprehensive review of relevant literature from the last five years retrieved from Medline, the initial text of the recommendations was formulated and consensus was sought among the experts. The consensus included statements that were agreed by more than 80% of the experts. This article presents the 24 consensus recommendations that were finally formulated.

摘要:HAE是一种罕见的疾病,表现为致残和潜在危及生命的血管性水肿的反复发作,早期诊断和有效治疗至关重要。最近的科学进步和新的治疗选择的发展已经在疾病的诊断和管理方面产生了多个重要的变化。为了鼓励和促进所有患者使用这一进展,希腊血管性水肿学会已经开始努力为特殊患者群体的遗传性血管性水肿的诊断、治疗和管理制定共识建议。为此目的,召集了一个由11名专家组成的小组,并使用了改进的德尔菲法。在对从Medline检索的过去五年的相关文献进行全面审查后,制定了建议的初步文本,并在专家之间寻求共识。这份共识包括了超过80%的专家同意的声明。本文提出了最终制定的24项共识建议。
{"title":"Consensus on diagnosis and management of hereditary angioedema in Greece.","authors":"A E Germenis, E Kompoti, G N Konstantinou, M Makris, E Manousakis, N Mikos, J Paraskevopoulos, M Speletas, E Stefanaki, E Farmaki, F Psarros","doi":"10.23822/EurAnnACI.1764-1489.405","DOIUrl":"https://doi.org/10.23822/EurAnnACI.1764-1489.405","url":null,"abstract":"<p><strong>Summary: </strong>HAE is a rare disease manifesting with recurrent attacks of disabling and potentially life-threatening angioedema for which early diagnosis and effective therapy are critical. Recent scientific progress and the development of novel therapeutic options has engendered multiple important changes in the diagnosis and management of the disease. In an attempt to encourage and facilitate the use of this progress for all patients, the Hellenic Society of Angioedema has undertaken the effort to develop consensus recommendations for the diagnosis, treatment and management of hereditary angioedema in special patients' groups. To this aim a panel of 11 experts was assembled and a modified Delphi method was used. After a comprehensive review of relevant literature from the last five years retrieved from Medline, the initial text of the recommendations was formulated and consensus was sought among the experts. The consensus included statements that were agreed by more than 80% of the experts. This article presents the 24 consensus recommendations that were finally formulated.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mixed rhinitis: an underestimated diagnosis in children and adolescents? 混合性鼻炎:儿童和青少年被低估的诊断?
IF 2.3 Q2 ALLERGY Pub Date : 2025-07-02 DOI: 10.23822/EurAnnACI.1764-1489.404
I Burla Manhães, F Y Matsumoto, D Solé, G F Wandalsen

Summary: Background. Mixed rhinitis (MR) is a potential diagnosis for patients with allergic rhinitis (AR) who present symptoms following exposure to allergens yet also exhibit a significant burden of symptoms after exposure to non-specific irritants. MR is thought to be more prevalent than the isolated form of the disease (AR). However, there are still no established complementary tests or well-defined clinical criteria for diagnosing this phenotype in children and adolescents. This study aimed to propose and evaluate a questionnaire of triggers that could assist in clinically distinguishing patients with MR from those with AR and, through it, to estimate the prevalence of MR in a specialty center. Methods. This study focused on patients aged 8 to 18 years diagnosed with AR and under follow-up for at least six months. All patients completed the nasal irritant questionnaire (NIQ) with 18 items. The number of responses with a score ≥ 5 was used to define tertiles. The group from the 3rd tertile onwards was described as "high irritant burden" (MR), while the others were defined as "low irritant burden" (AR). Additionally, symptom control scores, allergic sensitization, atopic comorbidities, and indoor exposure to aeroallergens were considered. Results. By using the diagnostic criterion of MR, defined as at least eight positive responses on the NIQ in a patient with AR, it was possible to determine that the prevalence of MR was 42.9% (54/126), with a predominance of males and adolescents (median 13 years) and a mean duration of 3 years since symptom onset. This group also exhibited poorer symptom control. Considering the other evaluated variables, no significant differences were observed between the groups. Conclusions. The prevalence of MR is significant among children with AR, and individuals with MR exhibit poorer symptom control. At least eight positive responses with a score ≥ 5 in the NIQ were a practical cut-off point for differentiating between AR and MR phenotypes.

摘要:背景。混合性鼻炎(MR)是变应性鼻炎(AR)患者的潜在诊断,这些患者在暴露于过敏原后出现症状,但在暴露于非特异性刺激物后也表现出显著的症状负担。MR被认为比孤立形式的疾病(AR)更为普遍。然而,在儿童和青少年中,仍然没有确定的补充测试或明确的临床标准来诊断这种表型。本研究旨在提出并评估一份触发因素问卷,该问卷可以帮助临床区分MR患者和AR患者,并通过它来估计MR在专业中心的患病率。方法。这项研究的重点是年龄在8至18岁之间的被诊断为AR的患者,随访时间至少为6个月。所有患者均完成鼻腔刺激问卷(NIQ),共18项。得分≥5分的应答数被用来定义分位数。从第三分位开始的组被描述为“高刺激负担”(MR),而其他组被定义为“低刺激负担”(AR)。此外,还考虑了症状控制评分、过敏致敏、特应性合并症和室内空气过敏原暴露。结果。通过使用MR的诊断标准,定义为AR患者在NIQ上至少有8个阳性反应,可以确定MR的患病率为42.9%(54/126),以男性和青少年为主(中位年龄为13岁),自症状出现以来平均持续时间为3年。该组也表现出较差的症状控制。考虑到其他评估变量,两组之间没有观察到显著差异。结论。MR患病率在AR儿童中显著,MR患者表现出较差的症状控制。NIQ评分≥5分的至少8个阳性反应是区分AR和MR表型的实际分界点。
{"title":"Mixed rhinitis: an underestimated diagnosis in children and adolescents?","authors":"I Burla Manhães, F Y Matsumoto, D Solé, G F Wandalsen","doi":"10.23822/EurAnnACI.1764-1489.404","DOIUrl":"10.23822/EurAnnACI.1764-1489.404","url":null,"abstract":"<p><strong>Summary: </strong><b>Background.</b> Mixed rhinitis (MR) is a potential diagnosis for patients with allergic rhinitis (AR) who present symptoms following exposure to allergens yet also exhibit a significant burden of symptoms after exposure to non-specific irritants. MR is thought to be more prevalent than the isolated form of the disease (AR). However, there are still no established complementary tests or well-defined clinical criteria for diagnosing this phenotype in children and adolescents. This study aimed to propose and evaluate a questionnaire of triggers that could assist in clinically distinguishing patients with MR from those with AR and, through it, to estimate the prevalence of MR in a specialty center. <b>Methods.</b> This study focused on patients aged 8 to 18 years diagnosed with AR and under follow-up for at least six months. All patients completed the nasal irritant questionnaire (NIQ) with 18 items. The number of responses with a score ≥ 5 was used to define tertiles. The group from the 3<sup>rd</sup> tertile onwards was described as \"high irritant burden\" (MR), while the others were defined as \"low irritant burden\" (AR). Additionally, symptom control scores, allergic sensitization, atopic comorbidities, and indoor exposure to aeroallergens were considered. <b>Results.</b> By using the diagnostic criterion of MR, defined as at least eight positive responses on the NIQ in a patient with AR, it was possible to determine that the prevalence of MR was 42.9% (54/126), with a predominance of males and adolescents (median 13 years) and a mean duration of 3 years since symptom onset. This group also exhibited poorer symptom control. Considering the other evaluated variables, no significant differences were observed between the groups. <b>Conclusions.</b> The prevalence of MR is significant among children with AR, and individuals with MR exhibit poorer symptom control. At least eight positive responses with a score ≥ 5 in the NIQ were a practical cut-off point for differentiating between AR and MR phenotypes.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144539626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acquired allergies in hematopoietic stem cell transplantation recipients: a case series analysis and literature review. 造血干细胞移植受者的获得性过敏:病例系列分析和文献综述。
IF 2.6 Q2 ALLERGY Pub Date : 2025-07-02 DOI: 10.23822/EurAnnACI.1764-1489.406
A M Limongiello, S Giammarco, L Di Marino, E Metafuni, A Aruanno, D Longhino, E Nucera, N Sacchi, S Pollichieni, P Chiusolo, S Sica
{"title":"Acquired allergies in hematopoietic stem cell transplantation recipients: a case series analysis and literature review.","authors":"A M Limongiello, S Giammarco, L Di Marino, E Metafuni, A Aruanno, D Longhino, E Nucera, N Sacchi, S Pollichieni, P Chiusolo, S Sica","doi":"10.23822/EurAnnACI.1764-1489.406","DOIUrl":"https://doi.org/10.23822/EurAnnACI.1764-1489.406","url":null,"abstract":"","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is gastrointestinal epithelial barrier dysfunction the only responsible for sensitization to food allergens? 胃肠道上皮屏障功能障碍是导致对食物过敏原过敏的唯一原因吗?
IF 2.6 Q2 ALLERGY Pub Date : 2025-07-01 Epub Date: 2024-11-22 DOI: 10.23822/EurAnnACI.1764-1489.378
R Asero, V Pravettoni, D Villalta, E Scala

Summary: Epithelial barriers are crucial defenses against pathogens and allergens, and recent theories suggest that environmental factors may compromise them, leading to type 2 inflammation and conditions such as asthma, atopic dermatitis, food allergy, and rhinitis. While skin and respiratory barriers show clear dysfunctions in allergies, the role of the gut epithelium is less defined, particularly in view of its ability to absorb nutrients and maintain immune tolerance under normal conditions. Research indicates that gastrointestinal barrier integrity typically remains preserved in food allergies, allowing for the development of immune tolerance to ingested food antigens through mechanisms like Treg cells and IgA. Allergies to cow's milk or hen's egg proteins most often resolve with age, highlighting the gut's evolving role in allergen sensitization. Studies like the LEAP (Learning Early About Peanut Allergy) trial demonstrate the preventive benefits of early allergen exposure against peanut allergy, supporting the dual allergen exposure hypothesis. New allergens such as alpha-Gal and gibberellin-regulated proteins (GRP) reveal distinct sensitization pathways beyond traditional ingestion routes, implicating non-dietary sources in allergen introduction. Altogether, there is lack of evidence suggesting that the intestinal epithelium is disrupted in food allergy.

摘要:上皮屏障是抵御病原体和过敏原的重要屏障,最近的理论认为,环境因素可能会损害上皮屏障,从而导致 2 型炎症以及哮喘、特应性皮炎、食物过敏和鼻炎等疾病。虽然皮肤和呼吸道屏障在过敏症中表现出明显的功能障碍,但肠道上皮细胞的作用却不太明确,特别是考虑到它在正常情况下吸收营养和维持免疫耐受的能力。研究表明,食物过敏患者的胃肠道屏障通常会保持完整,从而通过 Treg 细胞和 IgA 等机制对摄入的食物抗原产生免疫耐受。对牛奶或鸡蛋蛋白的过敏通常会随着年龄的增长而缓解,这凸显了肠道在过敏原致敏中不断演变的作用。LEAP(早期了解花生过敏)试验等研究表明,早期接触过敏原可预防花生过敏,支持双重过敏原接触假说。α-gal和赤霉素调节蛋白(GRP)等新过敏原揭示了传统摄入途径之外的独特致敏途径,表明过敏原的引入与非饮食来源有关。总之,缺乏证据表明食物过敏会导致肠上皮细胞受损。
{"title":"Is gastrointestinal epithelial barrier dysfunction the only responsible for sensitization to food allergens?","authors":"R Asero, V Pravettoni, D Villalta, E Scala","doi":"10.23822/EurAnnACI.1764-1489.378","DOIUrl":"10.23822/EurAnnACI.1764-1489.378","url":null,"abstract":"<p><strong>Summary: </strong>Epithelial barriers are crucial defenses against pathogens and allergens, and recent theories suggest that environmental factors may compromise them, leading to type 2 inflammation and conditions such as asthma, atopic dermatitis, food allergy, and rhinitis. While skin and respiratory barriers show clear dysfunctions in allergies, the role of the gut epithelium is less defined, particularly in view of its ability to absorb nutrients and maintain immune tolerance under normal conditions. Research indicates that gastrointestinal barrier integrity typically remains preserved in food allergies, allowing for the development of immune tolerance to ingested food antigens through mechanisms like Treg cells and IgA. Allergies to cow's milk or hen's egg proteins most often resolve with age, highlighting the gut's evolving role in allergen sensitization. Studies like the LEAP (Learning Early About Peanut Allergy) trial demonstrate the preventive benefits of early allergen exposure against peanut allergy, supporting the dual allergen exposure hypothesis. New allergens such as alpha-Gal and gibberellin-regulated proteins (GRP) reveal distinct sensitization pathways beyond traditional ingestion routes, implicating non-dietary sources in allergen introduction. Altogether, there is lack of evidence suggesting that the intestinal epithelium is disrupted in food allergy.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":" ","pages":"163-175"},"PeriodicalIF":2.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142686390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pollen-induced asthma: a unique model of mild to moderate asthma. 花粉性哮喘:一种独特的轻至中度哮喘模型。
IF 2.3 Q2 ALLERGY Pub Date : 2025-07-01 Epub Date: 2025-09-04 DOI: 10.23822/EurAnnACI.1764-1489.409
A Vaghi, M B Bilò, A Musarra
{"title":"Pollen-induced asthma: a unique model of mild to moderate asthma.","authors":"A Vaghi, M B Bilò, A Musarra","doi":"10.23822/EurAnnACI.1764-1489.409","DOIUrl":"https://doi.org/10.23822/EurAnnACI.1764-1489.409","url":null,"abstract":"","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":"57 5","pages":"195-196"},"PeriodicalIF":2.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145023106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes with one-bag desensitization protocol for biologic and chemotherapy agents in 451 procedures. 在 451 例手术中使用生物制剂和化疗药物单袋脱敏方案的结果。
IF 2.6 Q2 ALLERGY Pub Date : 2025-07-01 Epub Date: 2024-05-28 DOI: 10.23822/EurAnnACI.1764-1489.345
I Roibás-Veiga, P Méndez-Brea, M Castro-Murga, M González-Rivas, P Iriarte-Sotés, R López-Abad, S Cadavid-Moreno, T González-Fernández, S López-Freire, M Armisén, V Rodríguez-Vázquez, C Vidal
{"title":"Outcomes with one-bag desensitization protocol for biologic and chemotherapy agents in 451 procedures.","authors":"I Roibás-Veiga, P Méndez-Brea, M Castro-Murga, M González-Rivas, P Iriarte-Sotés, R López-Abad, S Cadavid-Moreno, T González-Fernández, S López-Freire, M Armisén, V Rodríguez-Vázquez, C Vidal","doi":"10.23822/EurAnnACI.1764-1489.345","DOIUrl":"10.23822/EurAnnACI.1764-1489.345","url":null,"abstract":"","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":" ","pages":"187-190"},"PeriodicalIF":2.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypersensitivity to lipoic acid. 对硫辛酸过敏。
IF 2.6 Q2 ALLERGY Pub Date : 2025-07-01 Epub Date: 2023-09-06 DOI: 10.23822/EurAnnACI.1764-1489.310
F Marchi, A Carabelli
{"title":"Hypersensitivity to lipoic acid.","authors":"F Marchi, A Carabelli","doi":"10.23822/EurAnnACI.1764-1489.310","DOIUrl":"10.23822/EurAnnACI.1764-1489.310","url":null,"abstract":"","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":" ","pages":"163-175"},"PeriodicalIF":2.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10516232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed postoperative reactions to metamizole: a diagnostic challenge. 甲氰咪唑术后延迟反应:诊断难题。
IF 2.6 Q2 ALLERGY Pub Date : 2025-07-01 Epub Date: 2023-12-05 DOI: 10.23822/EurAnnACI.1764-1489.317
A Lopes, M Paulino, A Spínola Santos, E Pedro, M Branco Ferreira

Summary: Background. Metamizole, a non-steroidal anti-inflammatory drug from the pyrazolone group, is a frequent cause of immediate hypersensitivity reactions and, more rarely, of delayed drug hypersensitivity reactions. Due to its favorable pharmacokinetic characteristics, metamizole is widely used in the postoperative period for pain control. Methods. Retrospective study of patients referred for allergological study between January 2012 and June2022 for postoperative hypersensitivity reactions. Clinical and diagnostic data were collected through review of patients' medical records. Twenty patients with postoperative hypersensitivity reactions were referred, of which 10 presented delayed reactions. We analyzed the results of skin prick, intradermal and patch tests performed with an intravenous metamizole solution as well as provocation tests performed with metamizole and acetylsalicylic acid. Cross-reactivity to non-steroidal anti-inflammatory drugs was excluded by confirmation of clinical tolerance to non-steroidal anti-inflammatory drugs or by acetylsalicylic acid provocation test. Results. In 7 of the 10 patients a delayed reaction to metamizole was diagnosed. These reactions were characterized as maculopapular exanthema, occurring in multiple postoperative settings. Skin tests were negative, except in one patient with late mild erythema in the ipsilateral upper limb and no reaction at the site of intradermal injection. Delayed hypersensitivity was demonstrated by late positive metamizole provocation tests. Conclusions. This study demonstrated that for a correct diagnosis a high degree of suspicion about possible delayed hypersensitivity drug reactions to metamizole in the postoperative setting is needed. In the investigation, provocation test with metamizole was decisive for diagnostic confirmation.

摘要:背景。甲硝唑是吡唑酮类的一种非甾体抗炎药,经常引起即刻超敏反应,更罕见的是迟发性药物超敏反应。由于其良好的药代动力学特性,甲硝唑被广泛用于术后止痛。研究方法回顾性研究 2012 年 1 月至 2022 年 6 月期间因术后超敏反应而转诊进行过敏学研究的患者。通过查阅患者病历收集临床和诊断数据。转诊了 20 例术后超敏反应患者,其中 10 例出现延迟反应。我们分析了使用静脉注射甲硝唑溶液进行的皮肤点刺、皮内和贴片试验以及使用甲硝唑和乙酰水杨酸进行的激发试验的结果。通过确认对非甾体类抗炎药物的临床耐受性或乙酰水杨酸激发试验,排除了对非甾体类抗炎药物的交叉反应。结果。10 名患者中有 7 人被诊断出对甲氰咪唑有迟发性反应。这些反应表现为斑丘疹性红斑,在术后多种情况下都会出现。除一名患者同侧上肢出现晚期轻度红斑,皮内注射部位无反应外,其他患者的皮试结果均为阴性。晚期甲氰咪唑激发试验呈阳性,证明存在迟发性超敏反应。结论。这项研究表明,为了做出正确诊断,需要高度怀疑术后可能出现的对甲氰咪唑的迟发性超敏反应。在调查中,使用甲氰咪唑进行激发试验对确诊起着决定性作用。
{"title":"Delayed postoperative reactions to metamizole: a diagnostic challenge.","authors":"A Lopes, M Paulino, A Spínola Santos, E Pedro, M Branco Ferreira","doi":"10.23822/EurAnnACI.1764-1489.317","DOIUrl":"10.23822/EurAnnACI.1764-1489.317","url":null,"abstract":"<p><strong>Summary: </strong><b>Background.</b> Metamizole, a non-steroidal anti-inflammatory drug from the pyrazolone group, is a frequent cause of immediate hypersensitivity reactions and, more rarely, of delayed drug hypersensitivity reactions. Due to its favorable pharmacokinetic characteristics, metamizole is widely used in the postoperative period for pain control. <b>Methods.</b> Retrospective study of patients referred for allergological study between January 2012 and June2022 for postoperative hypersensitivity reactions. Clinical and diagnostic data were collected through review of patients' medical records. Twenty patients with postoperative hypersensitivity reactions were referred, of which 10 presented delayed reactions. We analyzed the results of skin prick, intradermal and patch tests performed with an intravenous metamizole solution as well as provocation tests performed with metamizole and acetylsalicylic acid. Cross-reactivity to non-steroidal anti-inflammatory drugs was excluded by confirmation of clinical tolerance to non-steroidal anti-inflammatory drugs or by acetylsalicylic acid provocation test. <b>Results.</b> In 7 of the 10 patients a delayed reaction to metamizole was diagnosed. These reactions were characterized as maculopapular exanthema, occurring in multiple postoperative settings. Skin tests were negative, except in one patient with late mild erythema in the ipsilateral upper limb and no reaction at the site of intradermal injection. Delayed hypersensitivity was demonstrated by late positive metamizole provocation tests. <b>Conclusions.</b> This study demonstrated that for a correct diagnosis a high degree of suspicion about possible delayed hypersensitivity drug reactions to metamizole in the postoperative setting is needed. In the investigation, provocation test with metamizole was decisive for diagnostic confirmation.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":" ","pages":"176-183"},"PeriodicalIF":2.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138487065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European annals of allergy and clinical immunology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1